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Abstract
Background: The Effective Musculoskeletal Consumer Scale (EC-17) is a self-administered questionnaire for
evaluating self-management interventions that empower and educate people with rheumatic conditions. The aim
of the study was to translate and evaluate the Norwegian version of EC-17 against the necessary criteria for a
patient-reported outcome measure, including responsiveness to change.
Methods: Data quality, reliability, validity and responsiveness were assessed in two groups. One group comprising
103 patients received a questionnaire before and at the end of a self-management programme. The second group
comprising 96 patients’ received the questionnaire two weeks before and on arrival of the program. Internal
consistency and test-retest reliability were assessed. Construct validity was assessed through comparisons with the
Brief Approach/Avoidance Coping Questionnaire, (BACQ), the Emotional Approach Coping Scale (EAC) and the
General Health Questionnaire (GHQ-20). Responsiveness was assessed with the Standardised Response Mean (SRM).
Results: Respondents included 66 (64%) and 52 (54%) patients from the first and second groups respectively.
Levels of missing data were low for all items. There was good evidence for unidimensionality, item-total
correlations ranged from 0.59 to 0.82 and Cronbach’s Alpha and test-retest correlations were over 0.90. As
hypothesised EC-17 scores had statistically significant low to moderate correlations with the BACQ, EAC and GHQ-
20 in the range 0.26 to 0.42. Following the self-management program, EC-17 scores showed a significant
improvement with an SRM of 0.48.
Conclusion: The Norwegian version of the EC-17 has evidence for data quality, internal consistency and test-retest
reliability, construct validity and responsiveness to change. The EC-17 seems promising as an outcome measure for
evaluating self-management interventions for people with rheumatic conditions, but further studies are needed.
Background
Self-management programs are increasingly used as a
means to empower, educate and inform patients with
chronic rheumatic diseases. Such interventions are
designed to encourage patients to be more active and
take responsibility for their own health care with aims
of increased self-efficacy, coping with stress, problem
solving and interactions with healthcare professionals
[1,2]. Self-management programs have some evidence
for effectiveness [3-9]. Evaluation has, however, been
hindered by a lack of appropriate outcome measures
[10-12].
One-week self-management programs addressing the
needs of patients with different rheumatic diseases
have been developed at the Hospital for Rheumatic
Diseases in Lillehammer, Norway. Several patient-
reported outcome measures (PROMs) have been used
to evaluate these programs, including measures of dif-
ferent aspects of health status and quality of life
[1,4,13,14]. Such outcomes are important for assessing
long term benefits but may not be responsive to
important changes in the shorter to medium term
relating to patient skills in managing and taking an
active role in healthcare. Moreover, a systematic review
found that over 16 different outcome measures had
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[4]. This has important implications for generalisability
[15]. Another overview of evaluation of psychoeduca-
tional/self-management interventions presented more
than 30 different outcomes from 24 studies [1,16],
which indicate the complexity of the self-management
education. Different interventions, often delivered in
variety of environments and with different outcomes
make it difficult to compare results from one study/
intervention with another.
The OMERACT (Outcome Measures in Rheumatol-
ogy) Effective Musculoskeletal Consumer Project was
designed to address the need for appropriate outcome
measures for evaluating and comparing self-manage-
ment programs [15,17]. Previous research demonstrated
that existing outcome measures failed to assess a num-
ber of important skills, including the ability to find and
assess information, decision making and implementa-
tion, and to take part in the health care system and
society [15,17]. The Effective Musculoskeletal Consumer
Scale (EC-17) was developed to address the need for an
instrument that assesses skills and attributes of patients
as effective consumers who manage their healthcare,
which is an important part of self-management. It is
intended for use both to discriminate between patients
with different levels of skills and for assessing the out-
comes of interventions designed to improve skills. The
English language version of the EC-17 was found to be
acceptable to patients and have high internal consis-
tency. The aim of this study was to translate the English
language version of EC-17 [18] into Norwegian and
assesses the data quality, internal consistency and test-
retest reliability, construct validity and responsiveness to
change of the measure.
Methods
Data collection
Two groups of patients with rheumatic diagnoses, aged
25-85, participated in a one-week in- patient self-man-
agement program at the Hospital for Rheumatic Dis-
eases in Lillehammer, Norway. The recruitment of
patients took place from January to April 2007. Patients
in both samples were diagnosed and referred by rheu-
matologists and general practitioners from across Nor-
way. The patients, mostly females and with a disease
duration of over one year, received the invitation to par-
ticipate in the study together with a letter with the date
of their hospital stay. For purposes of assessing internal
consistency, validity and responsiveness to change, 103
patients were asked to complete the EC-17 before and
at the end of the one-week self-management program.
For purposes of assessing test-retest reliability, 96
patients were sent a postal version of the EC-17 two
weeks before attending the program and also completed
the questionnaire on arrival and at the end of the one-
week self-management program.
Intervention
The one-week self-management program summarised in
Table 1, is designed to help people manage their rheu-
matic disease and challenges in daily life. The program
has the same core concepts as outpatient programmes
and comprises information, discussions on how to cope
with the disease and daily life, cognitive management
skills, exercise, engagement in self-care and interactions
with healthcare professionals [2,4,19,20]. This program
is unique in that patients are hospitalized for the one
week program rather than participating in a series of
short modules that run over a long period of time. Dur-
ing the program, the inpatient education unit takes up
to 16 patients and 5 relatives per week within one diag-
nostic group. All patients receive a core program but
because patients with different diagnoses have different
needs, some programs have supplements. For example,
patients with ankylosing spondylitis have more physical
exercises, whereas fibromyalgia patients have more pro-
cess-orientated therapy related to stress management
and communication. Each educational session lasts for
1.5-2.5 hours and the physical activity sessions for 0.5-1
hour. In the evening group sessions, the patients are
divided into small groups of approximately five partici-
pants. Relatives have their own group. They talk
together for one hour under leadership of one health
Table 1 The Self-Management Program
Sunday Monday Tuesday Wednesday Thursday Friday
Living with chronic
disease (Nurse)
Coping with daily
activities (Occupational
Therapist)
Self-management
(Nurse)
Health and social welfare
(Social Worker)
Healthy eating
(Dietician)
Arrival in the
evening
Physical activity
Swimming-pool
(Physiotherapist)
Physical activity -
Nordic walking
Physical activity theory and
exercises (Physiotherapist)
Evaluation and end
of program (Nurse)
Information
regarding the
coming week
Consultation
rheumatologist
Rheumatic disease and
treatment
(Rheumatologist)
Creative activity
(Occupational
Therapist)
Group session Group session Group session
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on coping with the disease and daily life. Exercise facil-
ities including a swimming pool, are available in the eve-
ning for individual training.
Patients gave informed consent after receiving written
information about the project. The regional committee
for medical research ethics in Health Region East, Nor-
way and The Norwegian Data Inspectorate approved the
study.
Instruments
The EC-17 (Table 2) is a self-administered instrument
that was developed following a literature review, inter-
views with patients and physicians, feedback from
OMERACT members and pretesting with patients
[15,17]. The resulting questionnaire comprised 64 items
which was reduced to 17 items on the basis of expert
opinion and item testing [15]. The 17 items relate to
knowledge, attitudes and behaviours about self-manage-
ment skills with a five-point adjectival scale from ‘never’
to ‘always’. The results of principal component analysis
support the unidimensionality of the EC-17 [15]. The
items are summed and converted to produce a score
from 0 to 100 where 100 is the best possible score.
In the present study, the EC-17 translation followed
the forward and backwards procedure [21]. Two inde-
pendent bilingual translators including a health profes-
sional whose first language was Norwegian, translated
the original version of the EC-17 into Norwegian and
had a consensus meeting. Two independent bilingual
translators including a health professional whose first
language was English, then back translated the Norwe-
gian version and had a consensus meeting. The
Table 2 EC-17 item
a means (sd), frequencies, component loadings and item-total correlation (n = 116)
Scale/Item Mean
(sd)
Never Rarely Sometimes Usually Always Component
loading
b
Item-total
correlation
EC-17 total scores
c: 61.27
(16.88)
1. I know who can help me judge the quality of the
information I receive about my disease
2.41
(1.00)
9.5 44.8 26.7 14.7 4.3 0.69 0.65
2. I understand the information I receive about my
disease
2.85
(0.75)
12.1 68.1 15.5 1.7 2.6 0.66 0.62
3. I know how to adapt general health information to
my own situation
2.47
(0.84)
4.3 54.3 28.4 10.3 2.6 0.78 0.75
4. I can be clear about what is important in my life
when I make decisions about my disease
2.57
(0.85)
8.6 52.6 27.6 9.5 1.7 0.74 0.69
5. I can weigh the pros and cons of a decision about
my disease
2.67
(0.68)
6.9 57.8 31.9 2.6 0.9 0.68 0.63
6. I can set realistic goals about the management of
my disease
2.47
(0.80)
3.4 52.6 33.6 7.8 2.6 0.67 0.62
7. I can express my concerns well to health care
providers
2.65
(0.98)
16.4 48.3 22.4 9.5 3.4 0.77 0.74
8. I know how to ask good questions about my health
and my disease
2.36
(0.95)
4.3 52.6 21.6 18.1 3.4 0.85 0.82
9. I have built an open and trusting relationship, based
on mutual respect, with my health care providers
2.80
(1.01)
22.4 50.9 15.5 6.9 4.3 0.72 0.67
10. I am able to play the role I want to in my health
care team
2.52
(0.96)
10.3 50.0 24.1 12.1 3.4 0.64 0.60
11. I know who to work with to meet my health needs 2.46
(0.98)
8.6 50.9 22.4 13.8 4.3 0.82 0.79
12. I can be assertive to get what I need to meet my
health needs
2.02
(1.09)
6.9 32.8 26.7 25.9 8.6 0.73 0.69
13. I feel a sense of control over my disease 2.22
(0.92)
3.4 40.5 36.2 14.7 5.2 0.64 0.59
14. I feel confident in making decisions about my
health
2.45
(0.91)
8.6 44.0 34.5 9.5 3.4 0.80 0.76
15. I can negotiate with others about what we need to
do to manage my disease
2.28
(0.93)
2.6 46.6 32.8 12.1 6.0 0.78 0.74
16. I can negotiate with the health care system about
what to do to manage my disease
2.15
(1.02)
5.2 39.7 25.0 25.0 5.2 0.80 0.76
17. I can organize my life to act on decisions about
how to manage my disease
2.33
(0.95)
6.0 44.0 31.0 14.7 4.3 0.71 0.66
a EC-17 items use a five point scale, ranging from 0 to 4, were 0 is never and 4 is always.
b The two EC-17 components derived from principal component analysis had eigenvalues of 9.21 and 1.36.
c EC-17 total score is calculated by adding up the scores and converting to a scale from 0 to 100 where 100 is the best possible score.
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ward and back translation, resolving discrepancies
through consensus to achieve conceptual equivalence
between the Norwegian and original English version of
the EC-17.
The Norwegian version of the EC-17 was pre-tested
with ten inpatients with rheumatic diseases recruited
from patients in the hospitals rheumatology unit. All
patients were Norwegian speakers and had been diag-
n o s e dw i t hr h e u m a t o i da r t h r i t is, psoriatic arthritis or
ankylosing spondylitis. BH interviewed the patients fol-
lowing self-completion, asking them to provide feedback
on the questionnaire, including difficulty understanding
the questions.
All patients said that the questionnaire was compre-
hensible and no changes were necessary.
As part of testing for construct validity, the EC-17 was
compared to three instruments that assess coping and
psychological status. The 12-item Brief Approach/
Avoidance Coping Questionnaire (BACQ) is designed to
assess approach versus avoidance coping and comprises
two scales of approach and avoidance that cover cogni-
tive, emotional and action-related domains [22]. The
Norwegian version of the instrument has good evidence
for reliability and validity [22]. Items use a five-point
scale from disagree completely to agree completely and
produce two sum scores that range from 6 to 30 where
30 is the best possible score.
The 16-item Emotional Approach Coping Scale (EAC)
is designed to assess coping through emotional approach.
It comprises two scales: emotional processing, which
assesses active attempts to know and understand one’s
emotions, and emotional expression, which assesses
active verbal and nonverbal attempts to communicate or
symbolize one’s emotional experience [23,24]. The Nor-
wegian version of EAC is an acceptable and valid instru-
ment for measuring emotional processing and expression
in patients with rheumatic diseases [25]. Items use a
four-point scale from “Iu s u a l l yd o n ’td ot h i sa ta l l ” to “I
usually do this a lot” and produce two mean scores from
8 to 32 where 32 is the best possible score.
The General Health Questionnaire (GHQ-20) is a 20-
item screening instrument for detecting psychiatric disor-
ders, but is also used for measuring changes in psychoso-
cial status and psychological distress in chronic diseases
[26-30]. The instrument has evidence for reliability and
validity [26,31-33] and evidence for high sensitivity and
specificity in Norwegian trauma patients [26,32]. Items
use a four-point scale from no distress to severe distress
and sum to produce a total score from 0 to 60 where 0 is
the best possible score indicating no distress.
Statistical analysis
The EC-17 was assessed for missing data at the item
and scale level. Following the instrument developers,
principal component analysis (PCA) [34] was used to
assess the unidimensionality of the instrument after
assessing the ratio of the first to second eigenvalues
[15,34]. The ratios of 3:1 or higher were considered evi-
dence for unidimensionality [34]. Internal consistency
was assessed by item-total correlation and Cronbach’s
Alpha at the item and scale level respectively. Following
the findings of the instrument developers it was
expected that the 17 items would have levels of correla-
tion of over 0.4 with the remainder of the instrument.
The developers reported a Cronbach’s Alpha of 0.96 for
t h el o n g e r - f o r ms c a l ea n dA l p h aa n dt e s t - r e t e s ti n t r a -
class correlation coefficients of 0.9 and above meet the
more stringent reliability criterion for an outcome mea-
sure [35].
The construct validity of the EC-17 was evaluated
through comparisons with scores for the other three
instruments and patient characteristics. Pearson’sa n d
Spearman’s rank correlation were used for continuous
and categorical scales respectively. The association was
interpreted as being high, moderate and weak when the
correlation was over 0.60, between 0.30 and 0.60 and
0.30 or less, respectively [36]. It was hypothesised that
EC-17 scores would be moderately positively correlated
with BACQ Approach and negatively correlated with
BACQ Avoidance, moderately negatively correlated with
the GHQ-20 and moderately positively correlated with
EAC Expression and Processing. It was also hypothe-
sised that younger and more highly educated patients
would have higher EC-17 scores than older less well
educated patients resulting in weak positive correlations
with these two variables [37,38].
The responsiveness of the EC-17 was assessed by cal-
culating change scores for patients who had undertaken
the self-management program. The standardised
response mean (SRM) was calculated by dividing the
mean change in EC-17 scores over the one week period
by the standard deviation of the change scores. SRMs of
over 0.80, 0.40-0.80 and less than 0.40 were considered
high, moderate and small respectively [39,40].
SPSS for Windows (version 15.0) was used for statisti-
cal analysis.
Results
A total of 66 (64%) patients took part in the responsive-
ness testing and completed both questionnaires while 52
(54%) patients took part in the test-retest. There was no
drop-out among the 118 patients who accepted to parti-
cipate in the study, but two were excluded in the ana-
lyses because of too many missing items. Demographic
data and characteristics of the patients who underwent
the self-management program are shown in Table 3.
The majority of patients were females and age and dis-
ease duration were similar for both samples. Patients
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Page 4 of 8with fibromyalgia and Sjogrens syndrome were repre-
sented in both samples. There were no significant differ-
ences between responders and non-responders
regarding age, sex and diagnosis for the two groups.
EC-17 mean item scores at the start of the self-man-
agement program ranged from 2.02 for item 12 “I can
be assertive to get what I need to meet my health
needs” to 2.85 for item 2 “I understand the information
I receive about my disease” (Table 2). The levels of
missing data were low for all items.
PCA of item responses for all patients gave a two
component solution that explained 62.16% of the total
variation. The first component had an eigenvalue 9.21,
that was 6.76 times larger than the second component
of 1.36, which is adequate evidence for unidimensional-
ity [34]. Table 2 shows that the item-total correlations
ranged from 0.59 to 0.82 for the items “I feel a sense of
control over my disease” and “Ik n o wh o wt oa s kg o o d
questions about my health and my disease”, respectively.
Cronbach’s Alpha for the 17-item scale was 0.95. The
test-retest intraclass correlation coefficient was 0.90.
The results of testing for construct validity are shown
in Table 4. The correlation with the BACQ Approach
scale was significant and of a small to moderate level,
while there was no correlation with BACQ Avoidance.
The correlations with the EAC were of a lower level but
statistically significant. The correlation with the GHQ-
20 were also low but significant. There were no statisti-
cally significant correlations between EC-17 and age or
education.
There was a significant improvement in EC-17 scores
following the self-management program of 4.39 (sd =
9.25) on the 0-100 scale where 100 is the best possible
s c a l e( T a b l e5 ) .T h eS R Mw a s0 . 4 8w h i c hw a sl a r g e r
than SRMs for all but the GHQ-20 which produced an
SRM of 0.75.
Discussion
In this, study, we assessed the data quality, reliability,
validity and responsiveness of the Norwegian version of
the EC-17. Following forward backwards translation, the
Norwegian version was clearly understood by patients
involved in pre-testing the questionnaire. The 17-items
of the Norwegian EC-17 questionnaire had low levels of
missing data for the two groups of patients who took
part in the assessment of responsiveness and test-retest,
which is further evidence for the acceptability of the
instrument.
The results of PCA supported the unidimensionality
of the EC-17. Both internal consistency and test-retest
reliability estimates met widely accepted standards for
the use of such instruments. The coefficients also met
the more stringent criterion for use in individual
patients. The results of validity testing generally followed
the a priori hypotheses with EC-17 scores having low to
moderate correlations with the other questionnaires and
variables. However, there were no statistically significant
correlations with BACQ Avoidance, age and education.
The EC-17 was found to have evidence for responsive-
ness in this group of patients, however, responsiveness
should be further assessed at longer-term follow up and
in relation to other interventions that are designed to
improve self-management. It is also recommended that
other outcome measures are included alongside the EC-
17 including disease specific and general measures of
quality of life. This would promote further understand-
ing of the relationship between the skills and attributes
of patients as effective consumers and health outcomes
more generally.
The results of responsiveness testing for the EC-17
were, however, encouraging given the short one-week
interval of the study. From a self-management perspec-
tive, learning is a process, and to change attitudes and
Table 3 Mean (sd) patient characteristics
Test-retest Pre-post test
Respondents (n = 52) Non-respondents (n = 37) Respondents (n = 66) Non-respondents (n = 37)
Females n 51 (98%) 36 (97%) 60 (91%) 33 (89%)
Age, yrs 52.8 (13.0) 54.6 (9.6) 53.3 (12.1) 55.2 (12.7)
Disease duration, yrs, 6.6 (7.0) 7.4 (6,8)
Living alone 30 (58%) 17 (26%)
Education (<12 yrs) 29 (56%) 46 (70%)
Diagnoses:
Fibromyalgia 17 (33%) 14 (38%) 21 (32%) 7 (19%)
Sjogrens syndrome 17 (33%) 10 (27%) 7 (11%) 12 (32%)
Rheumatoid arthritis 9 (17%) 7 (19%)
Systemic Lupus Erythematosus 9 (17%) 6 (16%)
Osteoarthritis 22 (33%) 11 (30%)
Ankylosing spondylitis 10 (15%) 4 (11%)
Scleroderma 6 (9%) 3 (8%)
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week. There are three components of educational objec-
tives which form a hierarchy - affective, cognitive and
psychomotor - meaning that learning at the higher
levels is dependent on having attained prerequisite
knowledge and skills at lower levels [41]. Several items
within the EC-17 require high levels of knowledge, atti-
tudes and skills. The items 5 and 16 relating to weighing
up the cost and benefits of decisions relating to ones
disease and to negotiate with the health care system
about what to do to manage ones disease, are examples
of skills at high levels. It may also be that the self-man-
agement program was not as effective as intended and
hence large changes in the EC-17 could not be expected.
T h er e s p o n s er a t ef o rt h ep a t i e n t sr e s p o n d i n gb e f o r e
and after the management program was satisfactory at
64%, however the response rate of 54% for the test-ret-
est group was rather low. The comparison of respon-
dents and non-respondents showed, however, that there
were no significant differences in age, sex and diagnoses.
However, non-respondents were somewhat older in both
groups, indicating that selection bias can not be ruled
out.
The results of testing for construct validity were over-
all supportive of the hypotheses, however, the low corre-
lations between EC-17 scores and age and education
were insignificant. The correlation with age was even
positive, which was contrary to expectations. The inclu-
sion of very few younger patients who are expected to
be more consumer-minded, may have contributed to
this finding. Items within the EC-17 may not wholly
reflect consumer skills in practice but rather the subjec-
tive perceptions of patients. Patient responses may be
dependent on their expectations as consumers and users
of information. Finally, the development of the EC-17
which involved collaboration between people with
chronic rheumatic disease and health professionals [17],
where the participants gave feedback regarding rele-
vance, form and language, may have ensured that items
were of equal meaning and relevance to all groups of
patients thereby negating differential item functioning
across groups. These issues should be considered along-
side future evaluation and testing of the EC-17.
The original EC-17 which was developed and tested
with patients from Australia and Canada [15], is cur-
rently being used to evaluate a program for RA in Ire-
land and will in the near future be used in New Zealand
[15]. Our study provides the first evidence for a trans-
lated version of the EC-17 and we have demonstrated
that the instrument performs satisfactorily and compar-
ably with the original version. Furthermore, our study
provides additional evidence for construct validity.
Table 4 Pearson correlation coefficients between EC-17 scores and BACQ, EAC, GHQ-20 (n = 66), age and education (n
= 116)
Instrument Correlation P value
The Brief Approach/Avoidance Coping Questionnaire:
Approach 0.42 0.01
Avoidance - 0.07 0.57
Emotional Approach Coping Scale:
Processing 0.34 0.01
Expression 0.42 0.01
General Health Questionnaire-20 -0.26 0.05
Age 0.11 0.23
Education -0.00 0.98
Table 5 Mean (SD) scores and responsiveness of the EC-17, BACQ, EAC and GHQ-20 (n = 66)
Instrument Pre-test Post-test Change score SRM
a
EC-17
b 62.55 (15.34) 66.93 (13.37)** 4.39 (9.25) 0.48
EAC processing
c 2.83 (0.66) 2.93 (0.66) 0.10 (0.52) 0.19
EAC expression 2.76 (0.63) 2.82 (0.57) 0.06 (0.45) 0.13
BACQ Approach
d 3.42 (0.54) 3.54 (0.55) 0.12 (0.46) 0.25
BACQ Avoidance 3.24 (1.04) 3.10 (0.56) -0.14 (0.93) 0.15
GHQ-20
e 22.94 (9.96) 17.55 (8.89)** -5.39 (7.15) 0.75
a SRM standardised response mean = mean change in score divided by the standard deviation of the change in scores.
b EC-17 is scored from 0 to 100 where 100 is the best possible score.
c The EAC is scored from 1 to 4 where 4 is the best possible score.
d The BACQ is scored from 1 to 5 where 5 is the best possible score.
e GHQ-20 is scored from 0 to 60 where 0 is the best possible score.
Asterisks denote statistical significance: *p < 0.05; **p < 0.01.
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evaluations will serve to broaden the outcome measures
available for evaluating interventions and programs
designed to enhance patient skills. Moreover, there will
be greater scope for international collaboration and
meta-analyses if a common primary outcome measure
such as the EC-17 is agreed upon.
Patient education is described as one out of four main
responsibilities of the specialist health care within Nor-
way [42]. Most of the hospitals have established patient
education units where self-management programs are
widely implemented for groups of patients with chronic
diseases. Today, few instruments are available to mea-
sure effectiveness of such programs. The EC-17 is espe-
cially relevant for measuring effects of the self-
management programme described here, with instru-
ment content mirroring the goals of the programme. As
such the EC-17 provides important information for both
clinicians and policymakers within health care.
Conclusions
T h eE C - 1 7s h o w sg r e a tp r o m i s ea sam e a s u r eo ft h e
effectiveness of self-management programmes in
patients with rheumatic diseases. The questionnaire was
well understood by the patients and easy to complete.
The instrument has evidence for data quality, internal
consistency and test-retest reliability and validity. Preli-
minary evidence was also found for the responsiveness
of the EC-17, the instrument showing significant change
in patients completing a one week self-management
programme. However, further evaluative studies of the
EC-17 in different clinical settings are needed.
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